Literature DB >> 7050705

Acceleration of the body clearance of phenobarbital by oral activated charcoal.

M J Berg, W G Berlinger, M J Goldberg, R Spector, G F Johnson.   

Abstract

We investigated the effect of multiple oral doses of activated charcoal on the pharmacokinetics of intravenously administered phenobarbital in a randomized crossover trial. Six healthy men volunteered to take 200 mg of phenobarbital sodium per 70 kg of body weight intravenously on two separate occasions. On one occasion, each subject received oral activated charcoal (180 g) in divided doses over three days after the infusion of phenobarbital. Serum levels of phenobarbital were measured in all subjects up to 96 hours after the infusion, and urinary excretion of phenobarbital was measured in two subjects 24 to 96 hours after the infusion. A pharmacokinetic analysis showed that the charcoal decreased the serum half-life of phenobarbital form 110 +/- 8 to 45 +/- 6 hours (S.E.M.) (P less than 0.01), increased the total body clearance of phenobarbital from 4.4 +/- 0.2 to 12.0 +/- 1.6 ml per kilogram per hour (P less than 0.01), and increased the nonrenal clearance from 52 to 80 per cent of the total body clearance. We conclude that oral administration of activated charcoal enhances the nonrenal clearance of phenobarbital.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7050705     DOI: 10.1056/NEJM198209093071102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

Review 1.  Activated charcoal in the treatment of drug overdose. An update.

Authors:  W Palatnick; M Tenenbein
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

Review 2.  Pharmacokinetics of drugs in overdose.

Authors:  Y J Sue; M Shannon
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

3.  Effects of dosing interval on the pharmacokinetic and pharmacodynamic interactions between the oral adsorbent AST-120 and triazolam in humans.

Authors:  Tsutomu Kotegawa; Kimiko Tsutsumi; Hajime Morita; Hiromistu Imai; Misaki Morita; Tsuneaki Yoshizato; Tetsuji Ohyama; Shinya Uchida; Hiroshi Watanabe; Noriyuki Namiki; Kyoichi Ohashi
Journal:  Eur J Clin Pharmacol       Date:  2012-05-30       Impact factor: 2.953

Review 4.  Hepatotoxic mushroom poisoning: diagnosis and management.

Authors:  J Piqueras
Journal:  Mycopathologia       Date:  1989-02       Impact factor: 2.574

5.  Effect of oral activated charcoal on tobramycin clearance.

Authors:  R L Davis; J R Koup; R A Roon; K E Opheim; A N Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

6.  Case files of the toxikon medical toxicology fellowship in Chicago: the poisoned anesthesiologist.

Authors:  Trevonne M Thompson; Steven E Aks
Journal:  J Med Toxicol       Date:  2007-03

7.  Emergency medicine: the use of activated charcoal in cases of poisoning and drug overdose.

Authors:  T E Albertson; K R Olson; C J Fisher
Journal:  West J Med       Date:  1985-03

8.  Effect of oral cholestyramine on the elimination of high-dose methotrexate.

Authors:  R Erttmann; G Landbeck
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

Review 9.  Activated charcoal--past, present and future.

Authors:  R W Derlet; T E Albertson
Journal:  West J Med       Date:  1986-10

10.  Toxicokinetics of labeled amatoxins in the dog.

Authors:  H Faulstich; A Talas; H H Wellhöner
Journal:  Arch Toxicol       Date:  1985-01       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.